Tech Company Financing Transactions
Acclaro Medical Funding Round
Acclaro Medical, based in Smithfield, secured $23 million in investment from Accelmed and 3E Bioventures.
Transaction Overview
Company Name
Announced On
5/29/2025
Transaction Type
Venture Equity
Amount
$23,000,000
Round
Series B
Investors
Accelmed (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate the growth of its flagship products, UltraClear and AuraLux, and expedite global market expansion while advancing development of new products in its pipeline.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
333 George Washington Hwy
Smithfield, RI 02917
USA
Smithfield, RI 02917
USA
Phone
Website
Email Address
Overview
Founded in 2018 by world-class industry experts, Acclaro Medical is committed to developing, innovating, and bringing to market game-changing solutions to address today's unmet medical, aesthetic and surgical practice needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Helen Fang
Chief Technical Officer
Shlomo Assa
Browse more venture capital transactions:
Prev: 5/29/2025: Grammarly venture capital transaction
Next: 5/29/2025: Naoris Protocol venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs